总时间（秒）：14.32
问答时间（秒）：12.73

Based on the provided scientific literature, I will extract and standardize the required information according to the predefined JSON framework.

**Variants Include**

* Gene: a-synuclein (SNCA)
* Variants:
	+ HGVS: NM_000345.5:c.89C>T (standardized via API)
	+ cDNA Change:
		- Transcript: NM_000345.5
		- Ref: C
		- Alt: T
		- Position: 89
	+ Protein Change:
		- Ref: H
		- Alt: Y
		- Position: 30
	+ Description in input context: c.89C>T (p.H30Y)

**Described Disease**

* Described Disease: Parkinson's disease (PD)
* MONDO: MONDO:0005146

**Experiment Method**

* Assay Method: NMR spectroscopy
* Material used:
	+ Material Source: Recombinant a-synuclein protein
	+ Material Name: N/A
	+ Description: "The experiments were conducted using recombinant a-synuclein protein."
* Readout type: Quantitative
* Readout description:
	+ Variant: NM_000345.5:c.89C>T
	+ Conclusion: No change in amyloid fibril structure
	+ Molecular Effect: N/A
	+ Result Description: The A30P mutation does not cause changes in the number, location, and overall arrangement of β-strands in amyloid fibrils.
* Biological replicates:
	+ Biological replicates: Yes
	+ Description: "Three biological replicates were performed."
* Technical replicates:
	+ Technical replicates: N/A
* Basic positive control:
	+ Basic positive control: No
* Basic negative control:
	+ Basic negative control: N/A
* Validation controls P/LP:
	+ Validation controls P/LP: N/A
* Validation controls B/LB:
	+ Validation controls B/LB: N/A
* Statistical analysis method:
	+ Statistical analysis method: N/A
* Threshold for normal readout:
	+ Threshold for normal readout: N/A
* Threshold for abnormal readout:
	+ Threshold for abnormal readout: N/A
* Approved assay:
	+ Approved assay: Yes

Note that the experimental methods used in this study are generally accepted and widely used for studying amyloid fibril structure.

Here is the extracted information in JSON format:

```json
{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.5:c.89C>T",
          "cDNA Change": {
            "transcript": "NM_000345.5",
            "ref": "C",
            "alt": "T",
            "position": "89"
          },
          "Protein Change": {
            "ref": "H",
            "alt": "Y",
            "position": "30"
          },
          "Description in input context": "c.89C>T (p.H30Y)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease (PD)",
    "MONDO": "MONDO:0005146"
  },
  "Experiment Method": [
    {
      "Assay Method": "NMR spectroscopy",
      "Material used": {
        "Material Source": "Recombinant a-synuclein protein",
        "Material Name": "N/A",
        "Description": "The experiments were conducted using recombinant a-synuclein protein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.5:c.89C>T",
          "Conclusion": "No change in amyloid fibril structure",
          "Molecular Effect": "N/A",
          "Result Description": "The A30P mutation does not cause changes in the number, location, and overall arrangement of β-strands in amyloid fibrils."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": "N/A",
      "Basic positive control": "No",
      "Basic negative control": "N/A",
      "Validation controls P/LP": "N/A",
      "Validation controls B/LB": "N/A",
      "Statistical analysis method": "N/A",
      "Threshold for normal readout": "N/A",
      "Threshold for abnormal readout": "N/A",
      "Approved assay": "Yes"
    }
  ]
}
```